Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

-Anurag Rana, Bloomberg Intelligence Technology Analyst, recaps Oracle earnings. Oracle Corp. shares declined after the company reported quarterly capital expenses that were higher than estimates, raising investor concerns about the profitability of the AI infrastructure business.

-George Ferguson, Bloomberg Intelligence Senior Aerospace, Defense, & Airlines Analyst, discusses SpaceX’s IPO. Retail investors bidding for shares in SpaceX’s initial public offering have submitted more than $100 billion in orders, according to people familiar with the matter, as the potentially record-breaking debut enters the home stretch.

-Lily Meier, Bloomberg Retail Reporter, discusses the Bloomberg Big Take story: “Nike’s Savior CEO Is Grappling With a 45% Stock Slump.” Nike CEO Elliott Hill, a longtime company veteran, came out of retirement with much fanfare to right a sinking ship. Over a year in, not much is working – sales and shares are down and new products aren’t resonating. Competitors, meanwhile, are gaining traction among consumers, pushing Nike deeper into a hole with trying stay relevant.

See omnystudio.com/listener for privacy information.

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and John Tucker

- Woo Jin Ho, Bloomberg Intelligence Senior Hardware and Networking Analyst, discusses Super Micro Computer saying it plans $7 billion in equity and equity-linked financing transactions to fund component purchases to satisfy around $39 billion in AI server orders it has received from customers.

- Caroline Hyde, BTech Co Anchor, discusses SpaceX’s IPO. Gulf wealth funds have put in orders for shares worth several billions of dollars in SpaceX’s initial public offering. Saudi Arabia’s Public Investment Fund and Kuwait Investment Authority have each placed orders for shares worth $1 billion to $5 billion.

-Steve Man, Bloomberg Intelligence Global Autos and Industrials Research Analyst, discusses his research on Tesla and SpaceX. According to Bloomberg Intelligence: A Tesla-SpaceX merger looks far from assured in the medium term, widespread market speculation aside, as benefits from Terafab chip work, the Macrohard software development project and any Tesla role in space exploration are years away.

-Diana Rosero Pena, Bloomberg Intelligence Consumer Staples Analyst, discusses Chewy's earnings. Chewy shares drop after management gave additional guidance metrics on the conference call including cautious comments on customer additions, and profit measures. The company stated that it is seeing a “modest level of incremental pressure on premiumization and product attach rates” from its current customer base.

See omnystudio.com/listener for privacy information.

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney, Scarlet Fu, and John Tucker

-Dan Ives, Global Head of Technology Research at Wedbush Securities, discusses OpenAI becoming the third major artificial intelligence developer to confidentially file for a public listing, joining rivals in an IPO pipeline. The company is working with Goldman Sachs Group Inc. and Morgan Stanley on a potential listing as soon as the fall, according to people familiar with the matter.

-Carmen Arroyo, Bloomberg Tech Reporter, discusses the Bloomberg Big Take story: “SpaceX IPO Forces Investors to Bet on Musk’s Entangled AI Empire.” Elon Musk’s imperial approach has made it difficult to decipher his companies’ true valuations. With the SpaceX IPO looming, some investors have raised concerns about SpaceX’s accounting practices, corporate governance risks and related-party transactions with other Musk entities. And as Musk aims for the stars, some investors have grown anxious about whether his goals are attainable, or if he’s bending the rules to pursue them.

-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in biotech sector. Eli Lilly & Co. presented data showing its next-generation shot, retatrutide, can help patients lose 30% of their body weight over about two years.

-Jennifer Rie, Bloomberg Intelligence Senior Litigation Analyst, discusses Britain’s merger watchdog opening a probe into Paramount Skydance Corp.’s $110 billion takeover of Warner Bros. Discovery Inc. The Competition and Markets Authority has set an initial deadline of August 7 to rule on the deal, which would unite two Hollywood studios and major news networks.

See omnystudio.com/listener for privacy information.